Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

JP Morgan maintains its "overweight" rating on Zijin Gold International (02259) as the first quarter performance meets expectations.

Open-source securities: The long-term logic of insurance remains unchanged, optimistic about the opportunities for sector layout.

New stock news | Zhongji Innolight (300308.SZ) reportedly plans to go public in Hong Kong as early as June, aiming to raise $5 billion.
JP Morgan maintains its "overweight" rating on Zijin Gold International (02259) as the first quarter performance meets expectations.

Open-source securities: The long-term logic of insurance remains unchanged, optimistic about the opportunities for sector layout.

New stock news | Zhongji Innolight (300308.SZ) reportedly plans to go public in Hong Kong as early as June, aiming to raise $5 billion.

RECOMMEND

DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026

48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026

Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026


